These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 8015647)

  • 1. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump-driven extracorporeal circuits in patients with combined acute renal and hepatic failure.
    Davenport A; Will EJ; Davison AM
    Nephron; 1994; 66(4):431-7. PubMed ID: 8015647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of anticoagulation with heparin versus heparin plus epoprostenol in patients undergoing extracorporeal liver support with Prometheus.
    Krisper P; Tiran B; Fliser D; Haditsch B; Stadlbauer V; Otto R; Ernst T; Kretschmer U; Stauber RE; Haller H; Holzer H; Manns MP; Rifai K
    Artif Organs; 2010 Jan; 34(1):84-8. PubMed ID: 19663866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous haemofiltration in acute renal failure with prostacyclin as the sole anti-haemostatic agent.
    Fiaccadori E; Maggiore U; Rotelli C; Minari M; Melfa L; Cappè G; Cabassi A
    Intensive Care Med; 2002 May; 28(5):586-93. PubMed ID: 12029407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter.
    Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M
    Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration.
    Kozek-Langenecker SA; Spiss CK; Michalek-Sauberer A; Felfernig M; Zimpfer M
    Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticoagulation with prostaglandins and unfractionated heparin during continuous venovenous haemofiltration: a randomized controlled trial.
    Kozek-Langenecker SA; Spiss CK; Gamsjäger T; Domenig C; Zimpfer M
    Wien Klin Wochenschr; 2002 Feb; 114(3):96-101. PubMed ID: 12060975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticoagulation for continuous arteriovenous hemofiltration in children.
    Zobel G; Trop M; Muntean W; Ring E; Gleispach H
    Blood Purif; 1988; 6(2):90-5. PubMed ID: 3293620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulation of the extracorporeal circuit in chronic hemodialysis].
    Ryckelynck JP; Chouraqui D; Lobbedez T
    Nephrologie; 1998; 19(4):223-5. PubMed ID: 9675763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent.
    Zusman RM; Rubin RH; Cato AE; Cocchetto DM; Crow JW; Tolkoff-Rubin N
    N Engl J Med; 1981 Apr; 304(16):934-9. PubMed ID: 7010166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulant regimens in acute continuous hemodiafiltration: a comparative study.
    Bellomo R; Teede H; Boyce N
    Intensive Care Med; 1993; 19(6):329-32. PubMed ID: 8227722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodialysis without heparin.
    Woods HF; Weston MJ; Bunting S
    Proc Eur Dial Transplant Assoc; 1978; 15():122-9. PubMed ID: 368769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of isolated epoprostenol or associated to heparin for the maintenance of the patency of the continuous renal replacement technical circuits].
    Herrera-Gutiérrez ME; Seller-Pérez G; Lebrón-Gallardo M; De La Cruz-Cortés JP; González-Correa JA
    Med Intensiva; 2006 Oct; 30(7):314-21. PubMed ID: 17067504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional anticoagulation and antiaggregation for CVVH in critically ill patients: a prospective, randomized, controlled pilot study.
    Fabbri LP; Nucera M; Al Malyan M; Becchi C
    Acta Anaesthesiol Scand; 2010 Jan; 54(1):92-7. PubMed ID: 19650808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Continuous hemofiltration: an extrarenal filtration method used in intensive care].
    Journois D; Safran D
    Ann Fr Anesth Reanim; 1991; 10(4):379-89. PubMed ID: 1928860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysis.
    Caruana RJ; Smith MC; Clyne D; Crow JW; Zinn JM; Diehl JH
    Blood Purif; 1991; 9(5-6):296-304. PubMed ID: 1819317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of prostacyclin (epoprostenol) as anticoagulant in continuous renal replacement therapies: efficacy, security and cost analysis.
    Gainza FJ; Quintanilla N; Pijoan JI; Delgado S; Urbizu JM; Lampreabe I
    J Nephrol; 2006; 19(5):648-55. PubMed ID: 17136695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticoagulation for renal replacement therapy: different methods to improve safety.
    Oudemans-van Straaten HM; Fiaccadori E; Baldwin I
    Contrib Nephrol; 2010; 165():251-262. PubMed ID: 20427976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodialysis with prostacyclin (Epoprostenol) alone.
    Rylance PB; Gordge MP; Ireland H; Lane DA; Weston MJ
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():281-6. PubMed ID: 3887374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sustained low-efficiency dialysis in the ICU: cost, anticoagulation, and solute removal.
    Berbece AN; Richardson RM
    Kidney Int; 2006 Sep; 70(5):963-8. PubMed ID: 16850023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.